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Orofacial granulomatosis (OFG) is a rare, idiopathic disorder of the orofacial region. It is clinically characterized by persistent
and/or recurrent enlargement of the soft tissues of the oral and maxillofacial region, often manifesting as labial enlargement and
swelling of intraoral sites such as the gingiva, tongue, and buccal mucosa. Full-thickness mucosal biopsy reveals noncaseating
granulomatous inﬂammation, similar to Crohn’s disease and sarcoidosis. Thus, OFG must be distinguished from other chronic
granulomatous disorders. We report a case of a young female patient who presented with labial and maxillary gingival enlargement without any identiﬁable systemic causes, with suggested involvement of environmental triggers.

1. Introduction
The term orofacial granulomatosis (OFG) was ﬁrst coined by
Wiesenfeld et al. in 1985 to describe a rare granulomatous
inﬂammation in the orofacial area in the absence of a systemic
condition [1, 2]. Clinically, OFG presents as lip swelling often
with oral involvement, including the gingiva, tongue, and
buccal mucosa, without a clear origin of pathophysiology [2].
Histologically, the condition is marked by noncaseating
granulomas with lymphocytic inﬁltrate and epithelioid histiocytes [3]. Perivascular aggregation of histiocytes and
plasma cells may be observed along with dilated lymphatics in
the superﬁcial lamina propria [3]. Early medical intervention
is essential in preventing and minimizing permanent swelling,
functional impairment in speaking and eating, and emotional
distress from aesthetic appearance [2].

2. Case Presentation
A 9-year-old Caucasian female presented to the West Virginia University otolaryngology clinic with the chief complaint of gradually increasing swelling of her upper and
lower lips which started 4 months prior. The lip swelling was
reported to be very distressing to the child and her parents.
Prior to presentation at the otolaryngology clinic, the patient
was seen by a pediatric dentist, periodontist, and allergist.

The patient had a history of excessive thumb sucking,
wearing nail polish, and playing with homemade slime
containing glue, saline, shaving cream, and glitter. The
patient had a history of mild eczematous skin lesions and
vague rhinitis including nasal congestion, occasional postnasal drainage, varying complaints of headaches, and occasional conjunctival pruritus. Seasonal symptoms were
worse in spring time, with the pollens of trees, grasses, and
weeds possibly playing a role. There was no contributory
family history, medication history, or history of allergy to
food, drugs, or cosmetics. The patient did not have any
contributory past medical or surgical history.
Physical examination revealed a symmetrically enlarged,
erythematous upper lip with erythematous and edematous
maxillary anterior gingiva, particularly on the right side
(Figures 1 and 2). The allergist also noted mild ﬁssures in the
lip area, as well as evidence of cheilitis. The patient was
prescribed mupirocin ointment for the perioral areas where
the cheilitis was present in order to clear any superﬁcial
infection. This treatment likely resolved these issues prior to
patient presentation at the otolaryngology clinic.
The suggested diﬀerential diagnosis was Crohn’s disease,
sarcoidosis, tuberculosis, angioedema, and orofacial granulomatosis. Routine laboratory tests (basic metabolic
panel, complete blood count with diﬀerential, erythrocyte
sedimentation rate, hepatic function panel, HAV antibody,
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daily of prednisone for 2 weeks. The patient reported marked
improvement following oral steroid administration. Once
again, however, the patient experienced an exacerbation of
her OFG following swimming. She was treated again with
the same regimen of oral steroids. In addition, she avoided
foods containing benzoates as well as products containing
glitter, both of which seemed to be triggers for her OFG. The
patient experienced noticeable improvement in her gingival
hyperplasia and lip swelling following the treatment with
oral steroids and behavioral modiﬁcations.

3. Discussion
Figure 1: Prominent upper lip swelling with ﬁssures that had
persisted for four months.

Figure 2: Maxillary gingival hypertrophy associated with lip
swelling.

HCV antibody, HBV envelope antibody and antigen,
C-reactive protein, immunoglobulin panel, C4 complement,
C3 complement, glomerular basement membrane antibodies, and cytoplasmic neutrophil antibodies) were performed and were reported to be within normal limits. No
clinical signs or symptoms of gastrointestinal disease were
present.
A right upper lip incisional biopsy was performed.
Submucosal lymphohistiocytic inﬁltrate with loose perivascular granulomas were found. The underlying salivary
gland tissue was prominent with lymphocytic inﬁltrate with
occasional germinal center formation. Acid-fast bacilli were
not seen on a concentrated smear. The patient’s history,
physical examination, blood and serum tests, and pathology
results led to a diagnosis of OFG of the upper and lower lip
with maxillary gingival hyperplasia.
The patient was treated with azithromycin pulses for one
month. This treatment consisted of 500 milligrams once
daily for 3 days, followed by 4 days of no medication. This
regimen was followed for a total of 4 weeks as previously
described by De et al. in an eﬀort to avoid corticosteroids
given the parents’ concern for corticosteroid side eﬀects [1].
The patient saw improvement of symptoms following this
treatment. However, after using a lip gloss containing glitter,
she experienced an exacerbation of her oral swelling and
returned to the clinic. Given the perceived treatment failure,
the patient was subsequently treated with 40 milligrams once

OFG is a diagnosis of exclusion. A negative history of
gastrointestinal or pulmonary complaints precludes the
need for further consideration of Crohn’s disease or sarcoidosis, respectively [3]. The patient did present with many
symptoms of allergic angioedema including nonpitting
edema of the lips and face and history of atopic disease (e.g.,
vague rhinitis and mild eczema) [3]. However, granulomatous inﬂammation is not a feature of angioedema, and
thus this condition could be excluded [2]. Stains of the
biopsy specimen for acid-fast bacilli ruled out mycobacterial
infection. Thus, a diagnosis of OFG could be made with
negative ﬁndings for other possible conditions. The patient
was referred to pediatric rheumatology for continued
treatment.
The etiology and pathogenesis of OFG is unknown.
Many studies suggest a delayed hypersensitivity reaction
with an unlikely genetic component [3]. Several studies have
suggested a link between OFG and food allergy, allergy to
dental materials, and inappropriate immunological response
[3, 4]. In this patient’s case, there appeared to be clear
triggers for exacerbation of labial swelling. Her excessive
thumb sucking may not only exposed the oral region to
irritants, but may also caused trauma in the area that
contributed to excess swelling. The patient also chose to
eliminate benzoates, often found in food preservatives, from
her diet. Diets free of cinnamon and benzoates have been
shown to provide beneﬁt in 54–78% of patients diagnosed
with OFG, with 23% requiring no adjunctive therapy [5].
However, Campbell et al. more broadly suggested that OFG
is a heterogeneous condition where various triggers exist
that induce a similar inﬂammatory response in the orofacial
region, and dietary intervention as a monotherapy is not
recommended [6]. It is unclear if the benzoate- or glittercontaining products were the primary cause of OFG or
simply exacerbated the existing disease process. However,
the slow onset of symptoms does support a possible etiology
of delayed hypersensitivity reaction. Regardless, identiﬁcation of contributing factors and minimizing exposure to
these triggers have been proven to maximize treatment
eﬃcacy. This presents both the limitation and strength of
this case report. The temporal connections of the facial
swelling and possible environmental triggers increases the
evidence of immunological pathogenesis. This ﬁnding could
allow more conservative treatment modalities in environmental control and decrease the use of antibiotics, corticosteroid, and other immunological modulators. The
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limitation of this study is the patient was not tested for
immunological responses to the speciﬁc suspected triggers
nor were the triggers eliminated sequentially. Therefore, it is
unknown if avoidance of environmental triggers or corticosteroids was the eﬀective treatment. Another alternative
would be that the two therapies worked synergistically
achieving the favorable response. Rapid resolution of
symptoms was the goal of her management. While this
practice disallowed identiﬁcation of a sole trigger, we felt the
clinical improvement of the patient provided strong enough
evidence to support the avoidance of these irritants.
Early diagnosis and management of OFG is essential in
preventing permanent manifestations of the condition.
Repeated bouts of labial edema can result in permanent
induration and swelling that can functionally impair a patient’s ability to speak or eat, as well as cause a great deal of
emotional distress from facial disﬁgurement [7, 8]. Spontaneous remission of OFG is unlikely [3]. It is important to
continue monitoring patients and to treat with corticosteroids in order to prevent permanent change. Steroids have
been shown to be eﬀective in reducing and preventing recurrence of swelling [3].
Patients diagnosed with OFG are at risk to develop other
symptoms and conditions later. In particular, OFG has been
shown to be an early manifestation of Crohn’s disease, which
may present with gastrointestinal symptoms years later [9].
OFG can also be the ﬁrst presenting symptom of
Melkersson–Rosenthal Syndrome (MRS) [10]. This disease
manifests as a triad of recurrent labial enlargement, ﬁssured
tongue, and lower motor neuron facial palsy; histopathology
is consistent with OFG [3]. OFG is often considered a variant
and monosymptomatic form of MRS. Consequently, the
association between OFG and other conditions warrants
persistent clinical surveillance for the development of additional signs and symptoms.

4. Conclusion
OFG should be considered in the diﬀerential diagnosis for
nonspeciﬁc labial swelling in the absence of systemic disease.
Thorough history, physical exam, and laboratory investigation should be performed to exclude other etiologies.
Immediate treatment of OFG can prevent permanent deformity in the orofacial region. Corticosteroids are considered the mainstay treatment for OFG. However,
individual patient reports of dietary or environmental
triggers should be taken into consideration. The presented
case highlights that avoidance of reported triggers can help
minimize corticosteroid therapy. In addition, continued
monitoring is advised since OFG may be a precursor to other
related conditions.
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